Drugs developed today are increasingly effective, saving many patients' lives.
However, many of these novel drugs work only on specific subgroups of human diseases. For example, this is true for a range of cancer treatments. The modern cancer drugs work very effectively on a defined group of cancers. Each sub-type of cancer has a “finger print” which is characterized by elevations or absence of different proteins in the tissue (biological markers). Antibodies towards these biological markers are used as a tool to visualize the “finger print” and ultimately to identify the right patients for a certain cancer drug treatment. In the laboratory, these antibodies are usually used on patient test samples (blood or tissue) to define good matches between patient and drug.
Capra Science Antibodies produces many antibodies for pharmaceutical and diagnostic companies. Reliable, high quality antibodies are necessary to screen human samples and to identify the right patients for their highly specific drugs. These screening antibodies can be monoclonal or polyclonal antibodies.
However, many of these novel drugs work only on specific subgroups of human diseases. For example, this is true for a range of cancer treatments. The modern cancer drugs work very effectively on a defined group of cancers. Each sub-type of cancer has a “finger print” which is characterized by elevations or absence of different proteins in the tissue (biological markers). Antibodies towards these biological markers are used as a tool to visualize the “finger print” and ultimately to identify the right patients for a certain cancer drug treatment. In the laboratory, these antibodies are usually used on patient test samples (blood or tissue) to define good matches between patient and drug.
Capra Science Antibodies produces many antibodies for pharmaceutical and diagnostic companies. Reliable, high quality antibodies are necessary to screen human samples and to identify the right patients for their highly specific drugs. These screening antibodies can be monoclonal or polyclonal antibodies.
RSS Feed